Bastide le Confort Medical (FR:BLC) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Bastide le Confort Medical reports an annual revenue of 529.7 million euros, surpassing their target by 8.2% and achieving strong organic growth, particularly in the fourth quarter with a 9.5% increase. The company confirms its operational margin target of 8.4% for the 2023-2024 fiscal year and aims for over 560 million euros in revenue for the following year, focusing on home care services. They continue to prioritize deleveraging by selling assets with limited growth potential.
For further insights into FR:BLC stock, check out TipRanks’ Stock Analysis page.
